(SCHAUMBURG, Ill.)APP Pharmaceuticals Inc. said Tuesday U.S. regulators have cleared the way for its purchase by German dialysis-clinic operator Fresenius. In July, Hamburg-based Fresenius announced...READ MORE

(FRANKFURT, Germany)Dialysis products maker Fresenius Medical Care AG & Co. KGaA saw its net profit increase by 17 percent in the second quarter, according to preliminary figures released Thursday.READ MORE

(NEW YORK)Shares of APP Pharmaceuticals Inc. skyrocketed Monday after Germany's Fresenius SE said it will buy the U.S. generic drug maker for $3.7 billion in cash.READ MORE

(NEW YORK)Pharmaceutical shares were front and center in premarket trading Monday as U.S. markets appeared headed for a mixed open following the holiday weekend.READ MORE

(WASHINGTON)Fresenius Medical Care AG, a German dialysis services company, spent $550,000 lobbying the U.S. federal government in the first quarter, according to a recent disclosure report.READ MORE

(ROCKVILLE, Md.) Nabi Biopharmaceuticals said Thursday it has settled its patent-infringement case against Roxane Laboratories Inc. regarding Nabi's former product PhosLo GelCaps. The court d...READ MORE

(NEW YORK) A Wachovia analyst expects chatter surrounding a Medicare bill to escalate over the next two months, potentially causing volatility for certain health care providers' stocks. Ana...READ MORE